Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 6

The evaluation of breast findings detected through different visualisation techniques in acromegaly patients — a retrospective study

Sayfa
3073–3081
Yayın Tarihi
2022-11-06
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

A regular follow-up is required in these patients via suitable breast visualization techniques considering their age and clinical status due to mass formation risk derived from increased GH level and extreme breast density despite the absence of any detected breast lesion frequency in acromegaly patients.Key words: Acromegaly, breast density, breast neoplasm, breast cancer

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: It is known that the increased growth hormone (GH) and insulin-like growth factor-1 (IGF-1) have mitogenic and antiapoptotic properties in breast cells in acromegaly.
📊
Temel Bulgular & Veri:Materials and methods: Sixty-one patients followed with acromegaly diagnosis and 180 healthy controls were included in our study.
💡
Sonuç & Katkı:A regular follow-up is required in these patients via suitable breast visualization techniques considering their age and clinical status due to mass formation risk derived from increased GH level and extreme breast density despite the absence of any detected breast lesion frequency in acromegaly patients.Key words: Acromegaly, breast density, breast neoplasm, breast cancer
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: It is known that the increased growth hormone (GH) and insulin-like growth factor-1 (IGF-1) have mitogenic and antiapoptotic properties in breast cells in acromegaly. Our study aims to evaluate breast findings in patients with acromegaly by comparing them to the control group. Materials and methods: Sixty-one patients followed with acromegaly diagnosis and 180 healthy controls were included in our study. Demographic data, laboratory results, Breast Imaging-Reporting and Data System (BI-RADS) scores, and breast density evaluated via mammography, malign and benign breast lesions evaluated via mammography, breast ultrasonography (USG), and breast magnetic resonance imaging (MRI) of patients were compared to the control group. Results: While BI-RADS scores were similar in patient and control groups, breast density in acromegaly patients was found out to be higher compared to the control group (p = 0.754, p = 0.001, respectively). In acromegaly patients, the breast calcification rate was higher than controls (p = 0.021). t was observed that mass frequency in USG in acromegaly patients increased when GH level increased as well (p = 0.021). No difference was detected between benign and malign breast lesions diagnosed histopathologically (p = 0.031, p = 0.573, respectively). There was not any difference in terms of BI-RADS scores, breast types, and breast lesions in acromegaly patients that were in remission and not in remission (p > 0.05). Conclusion: Benign and malign breast lesions were found out to be similar to the control group, although breast density rate was detected to be higher in acromegaly patients. A regular follow-up is required in these patients via suitable breast visualization techniques considering their age and clinical status due to mass formation risk derived from increased GH level and extreme breast density despite the absence of any detected breast lesion frequency in acromegaly patients.Key words: Acromegaly, breast density, breast neoplasm, breast cancer

🔖

Bu Makaleye Atıf Yap

KIZILGÜL, M., ÇAKAL, E., SENCAR, M. E., BOSTAN, H., HEPŞEN, S., AKHANLI, P., DÜĞER, H., UÇAN, B. (2022). The evaluation of breast findings detected through different visualisation techniques in acromegaly patients — a retrospective study. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 6, 3073–3081. https://ajindex.com/articles/609347

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Dal J, Feldt-Rasmussen U, Andersen M, Kristensen LØ, Laurberg P et al. Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study. European Journal of Endocrinology 2016
  2. 175 (3): 181– 190. doi:10.1530/EJE-16-0117 2. Dal J, Leisner MZ, Hermansen K, Farkas DK, Bengtsen M et al. Cancer Incidence in Patients With Acromegaly: A Cohort Study and Meta-Analysis of the Literature. The Journal of Clinical Endocrinology and Metabolism 2018
  3. 103 (6): 2182– 2188. doi:10.1210/jc.2017-02457 3. Colao A, Grasso LFS, Giustina A, Melmed S, Chanson P et al. Acromegaly. Nature Reviews Disease Primers 2019
  4. 5 (1): 20. doi:10.1038/s41572-019-0071-6 4. Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM et al. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004
  5. 363 (9418): 1346–1353. doi:10.1016/ S0140-6736(04)16044-3 5. Renehan AG, Brennan BM. Acromegaly, growth hormone and cancer risk. Best Practice and Research Clinical Endocrinology and Metabolism 2008
  6. 22 (4): 639–657. doi:10.1016/j. beem.2008.08.011 6. Prisco M, Romano G, Peruzzi F, Valentinis B, Baserga R. Insulin and IGF-I receptors signaling in protection from apoptosis. Hormone and Metabolic Research 1999
  7. 31 (2-3): 80–89. doi:10.1055/s-2007-978703 7. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012
  8. 380 (9859): 2095–2128. doi:10.1016/S0140-6736(12)61728-0 8. Perry JK, Emerald BS, Mertani HC, Lobie PE. The oncogenic potential of growth hormone. Growth Hormone and IGF Research 2006
  9. 16 (5-6): 277–289. doi:10.1016/j. ghir.2006.09.006 9. Katznelson L, Laws ER, Melmed S, Molitch ME, Murad MH et al. Acromegaly: an endocrine society clinical practice guideline. The Journal of Clinical Endocrinology and Metabolism 2014
  10. 99 (11): 3933–3951. doi:10.1210/jc.2014-2700 10. D’Orsi CJ, Mendelson EB, Morris EA, et al. ACR BI-RADS: Breast Imaging Reporting and Data System. 5th ed. Reston, Va: American College of Radiology, 2012, n.d. 11. Moshina N, Sebuødegård S, Lee CI, Akslen LA, Tsuruda KM et al. Automated Volumetric Analysis of Mammographic Density in a Screening Setting: Worse Outcomes for Women with Dense Breasts. Radiology 2018
  11. 288 (2): 343–352. doi:10.1148/ radiol.2018172972 12. Wanders JOP, Holland K, Veldhuis WB, Mann RM,